Raymond James & Associates Mei Pharma, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
BUY
$0.41 - $8.8 $2,026 - $43,489
4,942 Added 28.38%
22,355 $9,000
Q4 2021

Feb 08, 2022
SELL
$2.33 - $3.37 $29,125 - $42,125
-12,500 Reduced 41.79%
17,413 $46,000
Q2 2020

Jul 28, 2020
BUY
$1.45 - $4.3 $15,950 - $47,300
11,000 Added 58.16%
29,913 $124,000
Q4 2019

Feb 12, 2020
BUY
$1.65 - $2.48 $31,206 - $46,904
18,913 New
18,913 $47,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email